These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34873292)

  • 21. Advances in Accurate Microbial Genome-Editing CRISPR Technologies.
    Lee HJ; Lee SJ
    J Microbiol Biotechnol; 2021 Jul; 31(7):903-911. PubMed ID: 34261850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decoding the microbiome: advances in genetic manipulation for gut bacteria.
    Chen Z; Jin W; Hoover A; Chao Y; Ma Y
    Trends Microbiol; 2023 Nov; 31(11):1143-1161. PubMed ID: 37394299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
    Liu T; Pan S; Li Y; Peng N; She Q
    Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and application of a CRISPR-Cas12a assisted genome-editing system in Zymomonas mobilis.
    Shen W; Zhang J; Geng B; Qiu M; Hu M; Yang Q; Bao W; Xiao Y; Zheng Y; Peng W; Zhang G; Ma L; Yang S
    Microb Cell Fact; 2019 Oct; 18(1):162. PubMed ID: 31581942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
    Xu Z; Li Y; Li M; Xiang H; Yan A
    Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems.
    Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ
    Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance.
    Kang YK; Kwon K; Ryu JS; Lee HN; Park C; Chung HJ
    Bioconjug Chem; 2017 Apr; 28(4):957-967. PubMed ID: 28215090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR based bacterial genome editing and removal of pathogens.
    Jothi R; Karthika C; Kamaladevi A; Satish L; Pandian SK; Gowrishankar S
    Prog Mol Biol Transl Sci; 2021; 179():77-92. PubMed ID: 33785178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
    Wilbie D; Walther J; Mastrobattista E
    Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CrisprGE: a central hub of CRISPR/Cas-based genome editing.
    Kaur K; Tandon H; Gupta AK; Kumar M
    Database (Oxford); 2015; 2015():bav055. PubMed ID: 26120138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA-guided DNA insertion with CRISPR-associated transposases.
    Strecker J; Ladha A; Gardner Z; Schmid-Burgk JL; Makarova KS; Koonin EV; Zhang F
    Science; 2019 Jul; 365(6448):48-53. PubMed ID: 31171706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CReasPy-Cloning: A Method for Simultaneous Cloning and Engineering of Megabase-Sized Genomes in Yeast Using the CRISPR-Cas9 System.
    Ruiz E; Talenton V; Dubrana MP; Guesdon G; Lluch-Senar M; Salin F; Sirand-Pugnet P; Arfi Y; Lartigue C
    ACS Synth Biol; 2019 Nov; 8(11):2547-2557. PubMed ID: 31663334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A versatile genetic engineering toolkit for E. coli based on CRISPR-prime editing.
    Tong Y; Jørgensen TS; Whitford CM; Weber T; Lee SY
    Nat Commun; 2021 Sep; 12(1):5206. PubMed ID: 34471126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering Citrobacter freundii using CRISPR/Cas9 system.
    Alfaro T; Elmore JR; Stromberg ZR; Hutchison JR; Hess BM
    J Microbiol Methods; 2022 Sep; 200():106533. PubMed ID: 35779647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
    Sharma S; Sharma CM
    Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editing the microbiome the CRISPR way.
    Ramachandran G; Bikard D
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180103. PubMed ID: 30905295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
    Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
    Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.
    Yan MY; Li SS; Ding XY; Guo XP; Jin Q; Sun YC
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.